I think IMU paid $9M upfront and then spent $10M on the manufacturing plant expense before offloading the cost which mean already $19M out of the total $50M CR for the Azer-Cel acquisition has been spent. So IMU will be diverting the $30M remainder of the CR to VAXINIA and OASIS clinical trials cost for the next few years. Only positive is a CR will likely not be required for a while but then there will be no benefit of the Azer-Cel IP for any T/O now.
Media Thread, page-14441
-
- There are more pages in this discussion • 1,205 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.8¢ |
Change
-0.002(4.00%) |
Mkt cap ! $356.9M | |||
| Open | High | Low | Value | Volume |
| 5.0¢ | 5.0¢ | 4.7¢ | $2.298M | 47.86M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 1925982 | 4.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.9¢ | 3452098 | 12 |
View Market Depth
| Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
| IMU (ASX) Chart |